Sage Therapeutics Inc. sell Bank of America Co.
Start price
09.10.24
/
50%
€5.99
Target price
09.10.25
€5.48
Performance (%)
26.80%
End price
10.10.25
-
Summary
This prediction is currently being closed. The prediction currently has a disappointing performance of 26.80%. Bank_of_America_Co_ has a follow-up prediction for Sage Therapeutics Inc. where he still thinks Sage Therapeutics Inc. is a Sell. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sage Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -1.432% | 0.000% | 12.331% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.688% |
| iShares Nikkei 225® | 1.448% | 5.269% | 18.051% |
| iShares S&P 500 | 0.114% | -0.217% | 1.388% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Sage Therapeutics Inc. diskutieren
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target lowered by analysts at Bank of America Co. from $11.00 to $6.00. They now have an "underperform" rating on the stock.
Ratings data for SAGE provided by MarketBeat
In the thread Trading Sage Therapeutics Inc.
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Bank_of_America_Co_ for Sage Therapeutics Inc.
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€6.76
11.03.25
11.03.25
€4.61
11.03.26
11.03.26
12.51%
31.07.25
31.07.25
